European regulator says benefits of Johnson & Johnson vaccine outweigh risks despite ‘possible link” to rare blood clots

AMSTERDAM (AP) — European regulator says benefits of Johnson & Johnson vaccine outweigh risks despite ‘possible link” to rare blood clots.

Copyright © 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up